Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
5E Advanced Materials | FEAM | Sep 4, 2024 | 0.68 | +2.04 |
60 Degrees Pharmaceuticals | SXTP | Sep 4, 2024 | 1.37 | -0.72 |
7-10 Yr Trsy Bear 3X Direxion | TYO | Sep 4, 2024 | 12.54 | -1.72 |
7-10 Yr Trsy Bull 3X Direxion | TYD | Sep 4, 2024 | 28.49 | +1.71 |
7-10 Yr Trsy Ishares | IEF | Sep 4, 2024 | 97.99 | +0.59 |
89bio | ETNB | Sep 4, 2024 | 8.80 | +0.23 |
8x8 | EGHT | Sep 4, 2024 | 1.77 | -2.75 |
908 Devices | MASS | Sep 4, 2024 | 3.73 | +0.27 |
99 Acquisition Group | NNAGU | Sep 4, 2024 | 10.74 | 0.00 |
99 Acquisition Group | NNAG | Sep 4, 2024 | 10.53 | +0.10 |
9F ADR | JFU | Sep 4, 2024 | 1.70 | +6.25 |
A SPAC I Acquisition Unit | ASCAU | Sep 4, 2024 | 2.96 | 0.00 |
A SPAC II Acquisition | ASCB | Sep 4, 2024 | 11.16 | 0.00 |
A-Mark Precious Metals | AMRK | Sep 4, 2024 | 40.32 | +0.98 |
a.k.a Brands | AKA | Sep 4, 2024 | 22.44 | +22.62 |
A.O Smith | AOS | Sep 4, 2024 | 80.35 | -1.12 |
A10 Networks | ATEN | Sep 4, 2024 | 13.50 | +0.15 |
A2Z Smart Technologies | AZ | Sep 4, 2024 | 0.61 | +0.71 |
AAA - A Rated Corporate Bond Ishares | QLTA | Sep 4, 2024 | 48.73 | +0.54 |
Aadi Bioscience | AADI | Sep 4, 2024 | 1.80 | +3.45 |
AAON | AAON | Sep 4, 2024 | 88.92 | -0.41 |
AAR | AIR | Sep 4, 2024 | 66.11 | +1.90 |
Abacus Life | ABL | Sep 4, 2024 | 10.14 | -0.30 |
Abbott Laboratories | ABT | Sep 4, 2024 | 114.40 | -0.23 |
AbbVie | ABBV | Sep 4, 2024 | 197.01 | -0.34 |
AbCellera Biologics | ABCL | Sep 4, 2024 | 2.52 | +0.80 |
Abeona Therapeutics | ABEO | Sep 4, 2024 | 5.57 | +2.01 |
Abercrombie & Fitch | ANF | Sep 4, 2024 | 139.66 | -2.29 |
Aberdeen Asia-Pacificome Fund | FAX | Sep 4, 2024 | 2.80 | -0.36 |
Aberdeen Australia Equity Fund | IAF | Sep 4, 2024 | 4.46 | 0.00 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.